Home › Uveal Melanoma › Pennsylvania
Uveal Melanoma clinical trials in Pennsylvania
8 studies for Uveal Melanoma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Wills Eye Hospital at Thomas Jefferson University, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07804186Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06070012Tebentafusp-tebn With LDT in Metastatic UM
- Thomas Jefferson University, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 21, 2026 · NCT06626516Neoadjuvant Tebentafusp for Uveal Melanoma
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06414590Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 8, 2026 · NCT03947385ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- University of Pennsylvania, Perelamn Center for Advanced Medicine, Philadelphia
- Thomas Jefferson University, Honickman Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Jefferson Health Honickman Center, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Thomas Jefferson University, Philadelphia
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 2/3
All ages · All sexes · Updated Apr 2, 2026 · NCT06581406From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.